Thursday, March 5, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Patient Survey: Understanding Healthcare Consumerism

Purpose: This survey explores how patients perceive healthcare consumerism, including choice, transparency, digital access, cost sensitivity, and trust. Responses reflect attitudes shaped by recent trends discussed at the JP Morgan Healthcare Conference.

Instructions: Please indicate how much you agree or disagree with each statement using the following scale:
1 = Strongly Disagree
2 = Disagree
3 = Neither Agree nor Disagree
4 = Agree
5 = Strongly Agree

I view myself as an active consumer when making healthcare decisions.
 The cost of care significantly influences where and when I seek medical services.
I expect to see prices or cost estimates before receiving non-emergency medical care.
I compare healthcare providers in the same way I compare other service providers (e.g., reviews, access, convenience).
 Digital tools (patient portals, apps, telehealth) strongly affect my satisfaction with a healthcare provider.
I am more likely to trust healthcare organizations that are transparent about outcomes and quality metrics.
Convenience (location, hours, virtual visits) matters as much to me as clinical expertise.
I feel comfortable asking my physician about lower-cost or alternative treatment options.
My insurance plan has made me more cost-conscious about my healthcare decisions.
I believe healthcare organizations should operate more like consumer-oriented service companies.
 I am willing to switch healthcare providers if my expectations around service or transparency are not met.
I expect healthcare to fit into my life, rather than rearranging my life around healthcare
I feel more engaged in my care when providers treat me as a partner in decision-making.
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

2027 Medicare Advantage & Part D Advance Notice

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!